文献速递造血干细胞移植与细胞治疗

接受干细胞移植患者的肠道通透性与全身急性期反应及菌群失调相关

Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis.
PubMed 文献 · Blood Adv · 2023-01-01

本研究采用改良乳果糖:鼠李糖(LR)比值法,在80例接受异基因造血干细胞移植(HSCT)的儿童和年轻成人患者中于移植前、+7天和+30天纵向评估肠道通透性,并同步进行粪便宏基因组测序和血浆标志物检测。结果显示+7天LR比值升高、+30天多数患者恢复基线(P=.014),高LR比值与菌群多样性降低(P=.035)、厌氧菌丢失(P=.020)及血浆脂多糖结合蛋白(LBP)升高(P=.0014)相关;LR试验耐受良好,可能识别更易发生不良结局的移植受者。

要点

  • 改良LR试验在HSCT受者中可行且耐受良好,未发生因LR导致的不良胃肠道反应。
  • +7天LR比值升高、+30天多数患者恢复基线(P=.014),预处理强度不影响LR轨迹(P=.39)。
  • 高LR比值与菌群多样性降低(P=.035)、厌氧菌丢失(P=.020)及血浆LBP升高(P=.0014)相关。

核心结论

  • 异基因HSCT后通过LR比值测定的肠道通透性与肠道菌群失调及血浆LBP升高相关。
  • LR试验耐受良好,可能识别更易发生不良结局的移植受者。

研究设计与样本

  • 前瞻性纵向研究,纳入80例接受异基因HSCT的儿童和年轻成人患者。
  • 于移植前、+7天和+30天施用改良LR试验,采用尿液质谱检测乳果糖和鼠李糖并以L:R比值表示。
  • 同时间点进行粪便宏基因组鸟枪法测序分析微生物组,并以酶联免疫吸附试验检测血浆LBP、ST2、REG3α、claudin1、occludin和肠道碱性磷酸酶。

主要发现

  • L:R比值在+7天升高、+30天多数患者恢复基线(P=.014)。
  • 预处理方案强度不影响L:R轨迹(P=.39);基线L:R比值不随诊断变化。
  • L:R与LBP水平相关(r2=0.208;P=.0014)。
  • 高L:R比值与微生物组多样性降低(P=.035)、厌氧菌丢失(P=.020)及血浆LBP升高(P=.0014)相关。
  • 未因LR发生不良胃肠道反应。

关键数值与推荐

  • 改良LR试验于移植前、+7天和+30天施用。
  • L:R比值在+7天升高、+30天多数患者恢复基线(P=.014)。
  • 高L:R比值与微生物组多样性降低(P=.035)、厌氧菌丢失(P=.020)及血浆LBP升高(P=.0014)相关。

临床怎么用

  • LR试验耐受良好,可能识别更易发生不良结局的移植受者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intestinal permeability may correlate with adverse outcomes during hematopoietic stem cell transplantation (HSCT), but longitudinal quantification with traditional oral mannitol and lactulose is not feasible in HSCT recipients because of mucositis and diarrhea. A modified lactulose:rhamnose (LR) assay is validated in children with environmental enteritis. Our study objective was to quantify peri-HSCT intestinal permeability changes using the modified LR assay. The LR assay was administered before transplant, at day +7 and +30 to 80 pediatric and young adult patients who received allogeneic HSCT. Lactulose and rhamnose were detected using urine mass spectrometry and expressed as an L:R ratio. Metagenomic shotgun sequencing of stool for microbiome analyses and enzyme-linked immunosorbent assay analyses of plasma lipopolysaccharide binding protein (LBP), ST2, REG3α, claudin1, occludin, and intestinal alkaline phosphatase were performed at the same timepoints. L:R ratios were increased at day +7 but returned to baseline at day +30 in most patients (P = .014). Conditioning regimen intensity did not affect the trajectory of L:R (P = .39). Baseline L:R ratios did not vary with diagnosis. L:R correlated with LBP levels (r2 = 0.208; P = .0014). High L:R ratios were associated with lower microbiome diversity (P = .035), loss of anaerobic organisms (P = .020), and higher plasma LBP (P = .0014). No adverse gastrointestinal effects occurred because of LR. Intestinal permeability as measured through L:R ratios after allogeneic HSCT correlates with intestinal dysbiosis and elevated plasma LBP. The LR assay is well-tolerated and may identify transplant recipients who are more likely to experience adverse outcomes.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Wang YM, Abdullah S, Luebbering N, et al. Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis. Blood Adv. 2023. PMID: 37083597. doi:10.1182/bloodadvances.2023009960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。